Related Experiment Video
Updated: May 1, 2026

Development of Compendium for Esophageal Squamous Cell Carcinoma
Published on: April 12, 2024
Decreased expression of ING2 gene and its clinicopathological significance in Chinese NSCLC patients
Abstract:
The inhibitor of growth 2 (ING2) is a member of lNG family, involved in cell cycle regulation, DNA repair, apoptosis and senescence, and participating in chromatin remodeling and transcriptional regulation by histone modification. Recent researches suggest ING2 plays roles in carcinogenesis both as tumor suppressor gene and ongocene depending on tumor types and cell status. Here, we investigated the status of ING2 in a series of 64 Chinese non-small cell lung cancer (NSCLC)patients using immunohistochemistry (IHC) and confirmed the results with Western blotting. RT-PCR results revealed the expression level of ING2 was consistent with mRNA level. The IHC results showed that ING2 protein expression was significantly decreased in NSCLC samples compared with normal lung tissues (P
Insights
Inhibitor of growth 2 (ING2) protein expression is significantly decreased in non-small cell lung cancer (NSCLC). This aberrant ING2 expression, including nuclear-to-cytoplasmic translocation, may contribute to NSCLC tumorigenesis.
Area of Science:
- Oncology
- Molecular Biology
- Genetics
Background:
- The inhibitor of growth 2 (ING2) is implicated in cell cycle regulation, DNA repair, and apoptosis.
- ING2's role in carcinogenesis varies, acting as either a tumor suppressor or oncogene.
- Understanding ING2's expression status in lung cancer is crucial.
Purpose of the Study:
- To investigate the expression status and potential role of ING2 in non-small cell lung cancer (NSCLC).
- To correlate ING2 expression with clinicopathological features in NSCLC patients.
Main Methods:
- Immunohistochemistry (IHC) was used to assess ING2 protein levels in 64 Chinese NSCLC patients and normal lung tissues.
- Western blotting and RT-PCR were employed to confirm protein and mRNA expression levels.
- ING2 gene sequencing was performed to detect mutations.
Main Results:
- ING2 protein expression was significantly decreased in NSCLC tissues compared to normal lung tissues (P<0.05).
- ING2 expression was lost in 32.8% of NSCLC cases, more prevalent in adenocarcinoma (45.8%) than squamous cell carcinoma (26.3%).
- ING2 translocation from nucleus to cytoplasm was observed, and its status in squamous cell carcinoma correlated with lymph node metastasis and TNM stage.
Conclusions:
- Aberrant expression of ING2, including decreased levels and cytoplasmic translocation, may contribute to NSCLC tumorigenesis.
- ING2 alterations are frequent in NSCLC, suggesting its potential as a biomarker or therapeutic target.
- No significant mutations or heterozygosity were found in the ING2 gene in the studied cohort.
More Related Videos
06:13Colony Formation Assay Detecting the Proliferative Capacity of LncRNA-knockdown Osteosarcoma Cells
Published on: January 16, 2026
09:08Integration of Bioinformatics Approaches and Experimental Validations to Understand the Role of Notch Signaling in Ovarian Cancer
Published on: January 12, 2020